USRE39815EExpiredUtility

Method for determining ion channel activity of a substance

Assignee: UNIV AUSTRALIANPriority: Sep 27, 1996Filed: Sep 26, 1997Granted: Sep 4, 2007
Est. expirySep 27, 2016(expired)· nominal 20-yr term from priority
C12Q 1/025
27
PatentIndex Score
0
Cited by
9
References
23
Claims

Abstract

A method for determining the ion channel activity of a substance comprises the steps of (i) expressing the substance as a heterologous protein in a host cell, and (ii) determining changes in permeability of the plasma membrane of the host cell induced by expression of the heterologous protein. A screening method for determining ion channel modulating activity of a test substance is also disclosed.

Claims

exact text as granted — not AI-modified
1. A screening method for determining ion channel modulating activity of a test substance having potential for such modulating activity, which comprises the steps of:
 (i) contacting a host cell with the test substance, said host cell expressing a peptide, polypeptide or protein in the plasma membrane of a host cell , said peptide, polypeptide or protein having ion channel activity when expressed as a heterologous protein in the plasma membrane of the host cell; and  
 (ii) contacting said host cell with the test substance; and 
 (iii)(ii) determining changes to the ion channel activity of said heterologous protein induced by the test substance, wherein the changes to the ion channel activity of the heterologous protein induced by the test substance are determined by detecting the effect of the test substance on changes in net movement across the plasma membrane of the host cell of small cellular metabolite molecules which do not directly permeate the ion channel formed by said heterologous protein.  
 
     
     
       2. A method according to  claim 1 , wherein the effect of the test substance on changes in the net movement of proline or adenine molecules across the plasma membrane is detected. 
     
     
       3. A method according to  claim 1 , wherein said host cell is E. coli. 
     
     
       4. A method according to  claim 1 , wherein said substance having ion channel activity is a heterologous cation channel protein. 
     
     
       5. A method according to  claim 4 , wherein said substance having ion channel activity is a heterologous sodium channel protein. 
     
     
       6. A method according to  claim 4 , wherein said substance having ion channel activity is the HIV-1 Vpu integral membrane protein. 
     
     
       7. A method according to  claim 1 , wherein leakage of said small cellular metabolite molecules from the host cell is detected. 
     
     
       8. A method according to  claim 7 , wherein leakage of said small cellular metabolite molecules from the host cells is detected by either:
 (i) cross-feeding of cells which are auxotrophic for the leaked metabolite; or  
 (ii) failure of cells expressing the ion channel to grow in the absence of the leaking metabolite being supplied in the external medium.  
 
     
     
       9. A method for determining ion channel modulating activity of a test substance having potential for such modulating activity, which comprises the steps of:
 (i) expressing a peptide, polypeptide or protein in the plasma membrane of a host cell, said peptide, polypeptide or protein having ion channel activity when expressed as a heterologous protein in the plasma membrane of the host cell;    (ii) contacting said host cell with the test substance; and    (iii) determining changes to the ion channel activity of said heterologous protein induced by the test substance, wherein the changes to the ion channel activity of the heterologous protein induced by the test substance are determined by detecting the effect of the test substance on changes in permeability of the plasma membrane of the host cell to small cellular metabolite molecules, wherein said heterologous protein having ion channel activity is the HIV-1 Vpu integral membrane protein.    
     
     
       10. The method of  claim 9   A screening method for determining ion channel modulating activity of a test substance having potential for such modulating activity, which comprises the steps of:
 ( i )  contacting a host cell with the test substance, said host cell expressing a peptide, polypeptide or protein in the plasma membrane, said peptide, polypeptide or protein having ion channel activity when expressed as a heterologous protein in the plasma membrane of the host cell; and    
 ( ii )  determining changes to the ion channel activity of said heterologous protein induced by the test substance, wherein the changes to the ion channel activity of the heterologous protein induced by the test substance are determined by detecting the effect of the test substance on changes in permeability of the plasma membrane of the host cell to small cellular metabolite molecules, wherein said heterologous protein having ion channel activity is the HIV-     1  Vpu integral membrane protein,   
 wherein the effect of the test substance on changes in the permeability of the plasma membrane to proline or adenine molecules is detected.  
 
     
     
       11. The method of  claim 9  wherein said host cell is E. coli. 
     
     
       12. The method of  claim 9  wherein leakage of metabolite from the host cell is detected. 
     
     
       13. The method of  claim 12  wherein leakage of metabolite from the host cells is detected by either:
 (i) cross-feeding of cells which are auxotrophic for the leaked metabolite; or    (ii) failure of cells expressing the ion channel to grow in the absence of the leaking metabolite being supplied in the external medium.    
     
     
       14. A screening method for determining ion channel modulating activity of a test substance having potential for such modulating activity, which comprises the steps of:
 (i) expressing HIV-1 Vpu integral membrane protein in the plasma membrane of a host cell, said protein having ion channel activity when expressed as a heterologous protein in the plasma membrane of the host cell;    (ii) contacting said host cell with the test substance; and    (iii) determining changes to the ion channel activity of said heterologous protein induced by the test substance, wherein the changes to the ion channel activity of the heterologous protein induced by the test substance are determined by detecting the effect of the test substance on changes in net movement across the plasma membrane of the host cell of small cellular metabolite molecules.    
     
     
       15. The method of  claim 14   A screening method for determining ion channel modulating activity of a test substance having potential for such modulating activity, which comprises the steps of:
 ( i )  contacting a host cell with the test substance, said host cell expressing HIV -   1  Vpu integral membrane protein in the plasma membrane, said protein having ion channel activity when expressed as a heterologous protein in the plasma membrane of the host cell; and    
 ( ii )  determining changes to the ion channel activity of said heterologous protein induced by the test substance, wherein the changes to the ion channel activity of the heterologous protein induced by the test substance are determined by detecting the effect of the test substance on changes in net movement across the plasma membrane of the host cell of small cellular metabolite molecules,   
 wherein the effect of the test substance on changes in the movement of proline or adenine molecules is detected.  
 
     
     
       16. The method of  claim 14  wherein said host cell is E. coli. 
     
     
       17. The method of  claim 14  wherein leakage of metabolite from the host cell is detected. 
     
     
       18. The method of  claim 17  wherein leakage of metabolite from the host cells is detected by either:
 (i) cross-feeding of cells which are auxotrophic for the leaked metabolite; or    (ii) failure of cells expressing the ion channel to grow in the absence of the leaking metabolite being supplied in the external medium.    
     
     
       19. A screening method for determining ion channel modulating activity of a test substance having potential for such modulating activity, which comprises the steps of:
 (i) expressing HIV-1 Vpu integral membrane protein in the plasma membrane of a host cell, said protein having ion channel activity when expressed as a heterologous protein in the plasma membrane of the host cell;    (ii) contacting said host cell with the test substance; and    (iii) determining changes to the ion channel activity of said heterologous protein induced by the test substance.    
     
     
       20. The method of  claim 19   A screening method for determining ion channel modulating activity of a test substance having potential for such modulating activity, which comprises the steps of:
 ( i )  contacting a host cell with the test substance, said host cell expressing HIV -   1  Vpu integral membrane protein in the plasma membrane, said protein having ion channel activity when expressed as a heterologous protein in the plasma membrane of the host cell; and    
 ( ii )  determining changes to the ion channel activity of said heterologous protein induced by the test substance,   
 wherein the effect of the test substance on changes in the permeability of the plasma membrane to proline or adenine molecules is detected.  
 
     
     
       21. The method of  claim 19  wherein said host cell is E. coli. 
     
     
       22. The method of  claim 19  wherein leakage of metabolite from the host cell is detected. 
     
     
       23. The method of  claim 22  wherein leakage of metabolite from the host cells is detected by either:
 (i) cross-feeding of cells which are auxotrophic for the leaked metabolite; or    (ii) failure of cells expressing the ion channel to grow in the absence of the leaking metabolite being supplied in the external medium.

Join the waitlist — get patent alerts

Track USRE39815E — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.